Fluorine F 18 FPyQCP

What is Fluorine F 18 FPyQCP?

Fluorine F 18 FPyQCP is a fibroblast activation protein (FAP)-targeted positron emission tomography tracer labeled with fluorine F 18. It binds to FAP-expressing tumor cells and cancer-associated fibroblasts in the tumor microenvironment. The tracer is being studied for imaging in colorectal, ovarian, gastric, breast, and pancreatic cancers.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as

[18F]FPyQCP

Drug type

Radiopharmaceutical

Targets

fibroblast activation protein (FAP)

Mechanism

Acts on fibroblast activation protein (FAP)

Therapy area

Oncology

In trials of

MEDP

FDA status

Investigational, not approved in the US. Most advanced trial: Phase 1/2

🧪 Clinical trials

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Colorectal CancerEpithelial Ovarian CancerGastric CancerInvasive Lobular Breast CarcinomaPancreatic Ductal Adenocarcinoma

Other drugs acting on FAP

Sources

• NCI Thesaurus
• ClinicalTrials.gov NCT07432633

Updated Oct 3, 2026.